Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

February 16, 2023
BioUtah News
R-Zero Raises $105 Million Series C to Improve the Indoor Air We Breathe

R-Zero’s UV-C Technology Improves Indoor Air Quality for Millions of People; Reduces Reliance on HVAC Systems and Chemicals that Harm Environment

February 16, 2023
BioUtah News
SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

Facility will produce high-performance ceramic armor products for personnel, aircraft, and vehicles

February 16, 2023
BioUtah News
SINTX Technologies Announces Closing of $12.0 Million Public Offering

SINTX Technologies Announces Closing of $12.0 Million Public Offering

February 9, 2023
BioUtah News
BioUtah on Capitol Hill

The Utah State Legislature has hit its halfway point in the 2023 session. Since day one, BioUtah President and CEO, Kelvyn Cullimore, and industry lobbyist, Chris Bleak, have been on the Hill engaging with lawmakers on a number of issues that impact our industry. Yesterday, Cullimore testified before the House Health and Human Services Committee […]

February 9, 2023
BioUtah News
February 9, 2023
BioUtah News
Renalytix announces a c.$20.3 million private placement

Renalytix announces a c.$20.3 million private placement

February 2, 2023
BioUtah News
Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in Multiple Sclerosis by Sanofi

SOUTH SAN FRANCISCO, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier for the treatment of neurodegenerative diseases and lysosomal storage diseases, today announced that its partner Sanofi has commenced dosing in a Phase 2 study […]

February 2, 2023
BioUtah News
Quansys Biosciences launches new NHP line of Multiplex ELISA Assays

NHP-specific ELISAs now available from Quansys Biosciences

January 30, 2023
BioUtah News
UTAH’S LIFE SCIENCES INDUSTRY TAKES TO THE HILL

Utah’s vibrant life sciences industry was on full display January 27 as part of the Governor’s Office of Economic Opportunity “Life Sciences Day on the Hill”. The event, held at the state capitol, provided lawmakers the opportunity to interact one-on-one with leaders from local med tech, biotech and diagnostics companies. More than two dozen companies […]

January 26, 2023
BioUtah News
BIOMERICS COMPLETES CONNECTICUT EXPANSION

SALT LAKE CITY, Jan. 20, 2023 /PRNewswire/ — Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced completion of a 26,000 sq. ft. expansion of its Monroe, CTfacility.  The Monroe facility is the headquarters of Biomerics’ micro-metals processing business and specializes in the design, development, and manufacture of complex […]

January 26, 2023
BioUtah News
Intermountain Healthcare is now “Intermountain Health”

Intermountain Healthcare has now officially changed its name to Intermountain Health, reflecting an added emphasis on keeping people healthy, as well as continuing to provide world-class medical care at its hospitals and clinics. Intermountain Health announced the name change in 2022 and that the name would be officially changed in 2023. The name change was […]

January 26, 2023
BioUtah News
DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease

DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease

January 26, 2023
BioUtah News
POSITIVE TWO-YEAR CLINICAL DATA ANNOUNCED FOR STUDY OF DISCOGENIC PROGENITOR CELL THERAPY (IDCT) FOR DEGENERATIVE DISC DISEASE

POSITIVE TWO-YEAR CLINICAL DATA ANNOUNCED FOR STUDY OF DISCOGENIC PROGENITOR CELL THERAPY (IDCT) FOR DEGENERATIVE DISC DISEASE

January 26, 2023
BioUtah News
Renalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United States

Award for consortium of industry, academic and clinical research leaders to develop personalized drug response tests in chronic kidney disease

January 26, 2023
BioUtah News
Halia Therapeutics Appoints Former Amgen Executive, Margit M. Janát-Amsbury, MD, Ph.D., as Chief Medical Officer

Halia Therapeutics announced the appointment of Dr. Margit M. Janát-Amsbury, MD, Ph.D. as the company’s Chief Medical Officer

January 11, 2023
BioUtah News
Advanced Practice Clinical Laboratory Training Center at ARUP Secures $3 Million in Federal Funding

ARUP Laboratories and the University of Utah’s Division of Medical Laboratory Sciences have secured $3 million in federal funding.

January 10, 2023
BioUtah News
Inherent Biosciences Partners With Posterity Health to Accelerate the Path to Parenthood by Elevating the Standard of Care in Male Reproductive Health

Inherent Biosciences has teamed up with Posterity Health, the only virtual Male Fertility Center of Excellence, to address male fertility

January 10, 2023
BioUtah News
Renalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systems

Significant milestone will make KidneyIntelX accessible to 960,000 veterans with chronic kidney disease

January 10, 2023
BioUtah News
Fluidx Unveils New Embolic for Neurovascular Use

New Catheter-Delivered Embolic Shows Promise for Treating Life-Threatening Bleeding around the Brain

January 5, 2023
BioUtah News
Nomi Health Hires Global Health and Technology Leader Amy Wykoff as Company’s First Chief Product Officer

Wykoff to build upon more than two decades of public and private sector healthcare leadership to head up delivering Nomi Health’s core business offerings

December 21, 2022
Policy News
HEALTHCARE POLICY FIGURES PROMINENTLY IN $1.7 TRILLION OMNIBUS GOVERNMENT FUNDING BILL

Congress is expected to vote this week on a massive omnibus government funding bill that would run through the end of the 2023 fiscal year. The legislative text was released on Tuesday. The $1.7 trillion, 4,155-page bill includes a number of significant healthcare provisions. Of particular interest to the life sciences industry are provisions included […]

December 21, 2022
BioUtah News
IONIQ is “Clinical Diagnostics Solution of the Year 2022”

IONIQ is “Clinical Diagnostics Solution of the Year 2022”

December 20, 2022
BioUtah News
IONIQ Science 2022 year-end update

For IONIQ Sciences, 2022 was another big year. As we respond to the FDA’s substantive review of our De Novo application for the ‘breakthrough‘ IONIQ ProLung Test, powerful macroeconomic factors are highlighting the importance of early cancer detection. Despite uncertain conditions in the financial market, we have a compelling message for potential institutional and strategic investors at […]

December 15, 2022
BioUtah News
2022 BIO Report Ranks Utah in the Top Eight States for Bioscience Specialization

The 2022 TEConomy/BIO report, The US Bioscience Industry: Fostering Innovation and Driving America’s Economy Forward, examines the bioscience industry’s impact on the national economy and provides state specific data, with Utah and its major metropolitan areas ranking high in specialized employment concentration in three major subsectors – medical device manufacturing, pharmaceuticals, research, testing and medical laboratories […]

December 14, 2022
BioUtah News
Participate in Life Sciences Day on the Hill

The annual Life Sciences Day on the Hill provides our industry with the opportunity to get face time with legislators and other government officials during the 2023 legislative session. Slated for Friday, January 27, 2023 from 11:00 AM to 2:00 PM, the event permits BioUtah members to demonstrate their important breakthroughs, devices and innovations. It […]

December 8, 2022
BioUtah News
Stryker launches state-of-the-art Neurovascular R&D lab with advanced technology to accelerate stroke care innovation

Stryker, one of the world’s leading medical technology companies, recently opened its Neurovascular (NV) lab, a state-of-the-art lab designed to accelerate stroke-related innovation in Asia Pacific. Located within the Stryker Global Technology Center (SGTC) at International Park, Gurgaon, India, the Keystone Suite will enable collaboration between customers, product development engineers, cross-functional teams, and other key […]

December 7, 2022
BioUtah News
Merrimack provides Ipsen report that Onivyde® regimen demonstrated statistically significant improvement in overall survival in previously untreated metastatic pancreatic ductal adenocarcinoma

Cambridge, MA, November 9, 2022 /Business Wire/ – Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] announced that Ipsen, SA (“Ipsen”) issued a press release today reporting its primary analysis of the results of its Phase III NAPOLI 3 trial of Onivyde® (irinotecan liposome injection) plus 5 fluorouracil/leucovorin and oxaliplatin (NALIRIFOX regimen) as a […]

December 1, 2022
BioUtah News
Utah Life Sciences Companies participate in Utah Trade Delegation to Medica 2022

Exhibiting their innovative products and services to over 80,000 visitors, 11 life science companies represented Utah at the MEDICA trade show in Düsseldorf, Germany. Looking across the global landscape of innovative healthcare products, Charlotte Serage, WTC Utah’s manager of trade shows and trade missions, said, “It’s clear that Utah is a major player.” Shoutout to EVŌQbio, Matia Mobility, NanoSpot.ai, SINTX […]

December 1, 2022
BioUtah News
Halia Therapeutics Presents at 4th Inflammasome Therapeutics Summit

SALT LAKE CITY–(BUSINESS WIRE)–Halia Therapeutics, a clinical stage biopharmaceutical company advancing innovative medicines to treat diseases driven by chronic inflammation, was invited to present today at the 4th Inflammasome Therapeutics Summit. Dr. David J. Bearss, CEO of Halia Therapeutics, will chair a panel entitled, “Advances in Proof-of-Concept Trials & Moving Towards the Clinic,” and also […]

December 1, 2022
BioUtah News
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023

LONDON and SALT LAKE CITY, Nov. 30, 2022 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today reported financial results for the fiscal first quarter ended September 30, 2022. Recent […]

December 1, 2022
BioUtah News
Ortho Development Launches Enabling Technology for Total Knee

by Julie A. Vetalice Ortho Development BKS Total PSI has been released for commercial distribution in the United States in collaboration with Materialise, a provider of additive manufacturing software and 3D printing solutions. BKS Total PSI is compatible with Ortho Development’s BKS and BKS TriMax total knee replacement systems. BKS Total PSI, powered by Materialise, […]